About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2011 (2011), Article ID 728930, 13 pages
http://dx.doi.org/10.1155/2011/728930
Review Article

Th1 Cytokine-Secreting Recombinant Mycobacterium bovis Bacillus Calmette-Guérin and Prospective Use in Immunotherapy of Bladder Cancer

Department of Urology, University of Iowa, 375 Newton Road, 3202 MERF, Iowa City, IA 52242, USA

Received 2 May 2011; Accepted 17 July 2011

Academic Editor: Ronald Herberman

Copyright © 2011 Yi Luo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [10 citations]

The following is the list of published articles that have cited the current article.

  • C. Biot, C. A. Rentsch, J. R. Gsponer, F. D. Birkhauser, H. Jusforgues-Saklani, F. Lemaitre, C. Auriau, A. Bachmann, P. Bousso, C. Demangel, L. Peduto, G. N. Thalmann, and M. L. Albert, “Preexisting BCG-Specific T Cells Improve Intravesical Immunotherapy for Bladder Cancer,” Science Translational Medicine, vol. 4, no. 137, pp. 137ra72–137ra72, 2012. View at Publisher · View at Google Scholar
  • Xiong Yang, Er-Lin Sun, Qi-Duo Shi, and Rui-Fa Han, “Toll-like receptor 4 expression of human peripheral blood mononulcar cells treated by recombinant hIFN-α-2b-BCG and its role of immune activation,” National Medical Journal of China, vol. 92, no. 20, pp. 1419–1423, 2012. View at Publisher · View at Google Scholar
  • Andrew M. Jackson, and Hester A. Franks, “Response to the rebuttal letter of Kountouras and colleagues regarding the paper by Codolo et al. 'HP-NAP inhibits the growth of bladder cancer in mic e by activating a cytotoxic Th1 response',” Cancer Immunology Immunotherapy, vol. 61, no. 3, pp. 449–451, 2012. View at Publisher · View at Google Scholar
  • M A Ingersoll, and M L Albert, “From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa,” Mucosal Immunology, 2013. View at Publisher · View at Google Scholar
  • Luigi Bernini, Carlo Umberto Manzini, Dilia Giuggioli, Marco Sebastiani, and Clodoveo Ferri, “Reactive arthritis induced by intravesical BCG therapy for bladder cancer: our clinical experience and systematic review of the literature,” Autoimmunity Reviews, 2013. View at Publisher · View at Google Scholar
  • Kevin Shenderov, Sho Yamasaki, Xin Lin, Jenny P.-Y. Ting, Giorgio Trinchieri, Gurdyal S. Besra, Vincenzo Cerundolo, Alan Sher, Daniel L. Barber, Katrin D. Mayer-Barber, Sudagar S. Gurcha, Dragana Jankovic, Carl G. Feng, Sandy Oland, Sara Hieny, and Pat Caspar, “Cord factor and peptidoglycan recapitulate the Th17-promoting adjuvant activity of mycobacteria through mincle/CARD9 signaling and the inflammasome,” Journal of Immunology, vol. 190, no. 11, pp. 5722–5730, 2013. View at Publisher · View at Google Scholar
  • Ahmad Nofal, Ayman Yosef, and Eman Salah, “Treatment of recalcitrant warts with Bacillus Calmette-Guérin: a promising new approach,” Dermatologic Therapy, 2013. View at Publisher · View at Google Scholar
  • Koji Kawai, Jun Miyazaki, Akira Joraku, Hiroyuki Nishiyama, and Hideyuki Akaza, “Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: Current understanding and perspectives on engineered BCG vaccine,” Cancer Science, vol. 104, no. 1, pp. 22–27, 2013. View at Publisher · View at Google Scholar
  • Ayman Yosef, Eman Salah, and Eman Nofal, “Intralesional Antigen Immunotherapy for the Treatment of Warts: Current Con cepts and Future Prospects,” American Journal Of Clinical Dermatology, vol. 14, no. 4, pp. 253–260, 2013. View at Publisher · View at Google Scholar
  • Juhua Zhou, Prakash Nagarkatti, Yin Zhong, Jay P. Ginsberg, Narendra P. Singh, and Jiajia Zhang, “Dysregulation in microRNA Expression Is Associated with Alterations in Immu ne Functions in Combat Veterans with Post-Traumatic Stress Disorder,” Plos One, vol. 9, no. 4, 2014. View at Publisher · View at Google Scholar